These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1087 related articles for article (PubMed ID: 2149421)

  • 1. The effect of BCG-activated macrophages on the B-16 melanoma.
    Papilian-Todoruţiu C; Rişcă R; Mulea R; Daicoviciu D
    Rom J Morphol Embryol; 1990; 36(2):129-34. PubMed ID: 2149421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-activated macrophages as effector cells in a tumour neutralization assay in vivo.
    Olstad R; Kaplan G; Seljelid R
    Acta Pathol Microbiol Immunol Scand C; 1983 Oct; 91(5):305-14. PubMed ID: 6362328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melanoma inhibits macrophage activation by suppressing toll-like receptor 4 signaling.
    Clarke JH; Cha JY; Walsh MD; Gamboni-Robertson F; Banerjee A; Reznikov LL; Dinarello CA; Harken AH; McCarter MD
    J Am Coll Surg; 2005 Sep; 201(3):418-25. PubMed ID: 16125076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BCG-induced production of a factor inhibiting macrophage migration and growth of melanoma B16].
    Gankovskaia LV; Pyl'nova TI; Sokolova EV; Koval'chuk LV
    Biull Eksp Biol Med; 1980 Sep; 90(9):346-8. PubMed ID: 7000202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of BCG and cyclophosphamide on the antitumor activity of mouse peritoneal macrophages].
    Gromov SA; Okulov VB; Voĭtenkov BO
    Eksp Onkol; 1989; 11(3):63-6. PubMed ID: 2752946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains.
    Kaptzan T; Skutelsky E; Itzhaki O; Sinai J; Michowitz M; Yossipov Y; Schiby G; Leibovici J
    Exp Gerontol; 2004 Jul; 39(7):1035-48. PubMed ID: 15236763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytochemical and cytophysiological study of in vivo BCG-activated mouse peritoneal macrophages.
    Todoruţiu-Papilian C; Mulea R; Daicoviciu D
    Morphol Embryol (Bucur); 1985; 31(4):283-8. PubMed ID: 2934625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary T-cell and activated macrophage response associated with tumor protection using peptide/poly-N-acetyl glucosamine vaccination.
    Maitre N; Brown JM; Demcheva M; Kelley JR; Lockett MA; Vournakis J; Cole DJ
    Clin Cancer Res; 1999 May; 5(5):1173-82. PubMed ID: 10353754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of activated macrophages in C3H/HeJ mice by avirulent Salmonella.
    Schafer R; Nacy CA; Eisenstein TK
    J Immunol; 1988 Mar; 140(5):1638-44. PubMed ID: 3279120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific bacteriophages induce tumor destruction through activation of tumor-associated macrophages.
    Eriksson F; Tsagozis P; Lundberg K; Parsa R; Mangsbo SM; Persson MA; Harris RA; Pisa P
    J Immunol; 2009 Mar; 182(5):3105-11. PubMed ID: 19234207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acetylic salicylic acid and pentoxifylline on the efficacy of intravesical BCG therapy in orthotopic murine bladder cancer (MB49).
    Günther JH; Frambach M; Deinert I; Brandau S; Jocham D; Böhle A
    J Urol; 1999 May; 161(5):1702-6. PubMed ID: 10210443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimetastatic activity induced by Clostridium butyricum and characterization of effector cells.
    Chen HY; Wu SL; Yeh MY; Chen CF; Mikami Y; Wu JS
    Anticancer Res; 1993; 13(1):107-11. PubMed ID: 8476200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity.
    Mangsbo SM; Ninalga C; Essand M; Loskog A; Tötterman TH
    J Immunother; 2008 Jan; 31(1):34-42. PubMed ID: 18157010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tumor-inhibitory macrophages with a novel synthetic immunomodulator, 3,6-bis(2-piperidinoethoxy)acridine trihydrochloride (CL 246,738).
    Wang BS; Lumanglas AL; Ruszala-Mallon VM; Durr FE
    J Immunol; 1985 Jul; 135(1):679-83. PubMed ID: 3839006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of BCG (Bacillus Calmette Guérin) sensitization on the generation of tumor specific killer T cells].
    Takeuchi M; Kimoto M; Suzuki I; Nomoto K
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1980-6. PubMed ID: 6604499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous accumulation of IFN-gamma in IFN-gamma-R(-/-) mice increases resistance to B16F10-Nex2 murine melanoma: a model for direct IFN-gamma anti-tumor cytotoxicity in vitro and in vivo.
    Rodrigues EG; Garofalo AS; Travassos LR
    Cytokines Cell Mol Ther; 2002; 7(3):107-16. PubMed ID: 12850810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of B-16 melanoma and Lewis lung carcinoma to BCG immunoprophylaxis.
    Papilian-Todoruţiu C; Daicoviciu D
    Morphol Embryol (Bucur); 1987; 33(1):55-69. PubMed ID: 2953967
    [No Abstract]   [Full Text] [Related]  

  • 20. Divergent changes in antimicrobial activity after immunologic activation of mouse peritoneal macrophages.
    van Dissel JT; Stikkelbroeck JJ; van den Barselaar MT; Sluiter W; Leijh PC; van Furth R
    J Immunol; 1987 Sep; 139(5):1665-72. PubMed ID: 2957432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.